Vanessa is a trusted trial lawyer for life sciences and high-tech companies in their most complex and high-stakes disputes. From conflicts between key competitors and licensing partners to billion-dollar tax controversies, Vanessa guides clients through mission-critical litigation with clarity and results. She handles disputes involving a range of emerging and cutting-edge technologies, including biologics, gene therapy, peptides, complex nanomolecules, and software.

Vanessa has litigated numerous cases in United States federal courts, securing wins in high-pressure and high-value matters. Recent highlights include successfully defending patents covering the blockbuster medication Ozempic® and setting taxpayer-favorable precedent in a U.S. Tax Court case involving online software tax deductions. She began her career in Canada, where she litigated several of the country's first biologics and biosimilars patent trials—building experience as a skilled advocate in first-of-their-kind cases involving complex technologies.

Clients rely on Vanessa not only in the courtroom, but also behind the scenes. She regularly advises clients on global IP litigation strategy, enforcement, and risk mitigation, including transactional matters related to patent rights and portfolio analysis. Her deep litigation experience allows her to spot issues early and design strategies for the best results when disputes do arise.